![Michael E. Markels](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Historial de carrera de Michael E. Markels
Antiguos cargos conocidos de Michael E. Markels.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
BIOGEN INC. | Ventas & Marketing | 01/05/2006 | 01/05/2006 |
INTERMUNE INC | Corporate Officer/Principal | 01/10/2002 | 01/10/2002 |
Glaxo Wellcome, Inc. | Corporate Officer/Principal | 01/01/2001 | 01/01/2001 |
NEUROGESX, INC | Corporate Officer/Principal | 01/05/2006 | - |
Formación de Michael E. Markels.
Colorado State University | Undergraduate Degree |
Duke University | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 7 |
Operativa
Corporate Officer/Principal | 3 |
Sales & Marketing | 1 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 5 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
BIOGEN INC. | Health Technology |
Empresas privadas | 3 |
---|---|
Glaxo Wellcome, Inc. | Health Technology |
InterMune, Inc.
![]() InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
NeurogesX, Inc.
![]() NeurogesX, Inc. Pharmaceuticals: MajorHealth Technology NeurogesX, Inc. developed and commercialized novel pain management therapies. The company was founded by Wendye R. Robbins on May 28, 1998 and was headquartered in San Mateo, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Michael E. Markels
- Experiencia